Bharat Parenterals [BPLPHARMA] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Bharat Parenterals Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Bharat Parenterals Ltd. wins in 8 metrics, Innova Captab Ltd. wins in 11 metrics, with 0 ties. Innova Captab Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bharat Parenterals Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) -18.20 31.20 Innova Captab Ltd.
Price-to-Book Ratio 1.90 4.05 Bharat Parenterals Ltd.
Debt-to-Equity Ratio 39.74 32.95 Innova Captab Ltd.
PEG Ratio -0.45 1.33 Innova Captab Ltd.
EV/EBITDA 11.90 20.49 Bharat Parenterals Ltd.
Profit Margin (TTM) -2.32% 8.85% Innova Captab Ltd.
Operating Margin (TTM) -10.30% 12.88% Innova Captab Ltd.
EBITDA Margin (TTM) N/A 12.88% N/A
Return on Equity -3.72% 13.37% Innova Captab Ltd.
Return on Assets (TTM) -1.95% 8.12% Innova Captab Ltd.
Free Cash Flow (TTM) $-563.30M $-1.09B Bharat Parenterals Ltd.
Dividend Yield 0.08% 0.30% Innova Captab Ltd.
1-Year Return 10.27% -3.19% Bharat Parenterals Ltd.
Price-to-Sales Ratio (TTM) 2.39 2.76 Bharat Parenterals Ltd.
Enterprise Value $4.88B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 1.39 2.90 Bharat Parenterals Ltd.
Gross Profit Margin (TTM) 50.44% 35.19% Bharat Parenterals Ltd.
Revenue per Share (TTM) $553 $262 Bharat Parenterals Ltd.
Earnings per Share (Diluted) $-42.80 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.57 -0.33 Innova Captab Ltd.

Bharat Parenterals Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

BPLPHARMA
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bharat Parenterals Ltd.7.15%7.11%11.16%24.46%18.70%15.70%
Innova Captab Ltd.-0.63%1.28%1.49%32.44%19.52%16.05%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bharat Parenterals Ltd.10.27%274.77%198.94%895.74%895.74%895.74%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Bharat Parenterals Ltd. vs Innova Captab Ltd.

MetricBPLPHARMAINNOVACAP
Market Information
Market Cap i₹8.36B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,929578,151
90 Day Avg. Volume i2,703217,693
Last Close₹1,400.00₹857.00
52 Week Range₹880.25 - ₹1,667.20₹622.00 - ₹1,020.70
% from 52W High-16.03%-16.04%
All-Time High₹1,870.00 (Dec 02, 2024)₹1,260.00 (Jan 06, 2025)
% from All-Time High-25.13%-31.98%
Growth Metrics
Quarterly Revenue Growth-0.10%0.42%
Quarterly Earnings Growth-0.10%0.23%
Financial Health
Profit Margin (TTM) i-0.02%0.09%
Operating Margin (TTM) i-0.10%0.13%
Return on Equity (TTM) i-0.04%0.13%
Debt to Equity (MRQ) i39.7432.95
Cash & Liquidity
Book Value per Share (MRQ)₹640.06₹178.28
Cash per Share (MRQ)₹64.78₹10.22
Operating Cash Flow (TTM) i₹-654,312,000₹282.88M
Levered Free Cash Flow (TTM) i₹-126,262,000₹1.28B
Dividends
Last 12-Month Dividend Yield i0.08%0.30%
Last 12-Month Dividend i₹1.00₹2.00

Valuation & Enterprise Metrics Analysis: Bharat Parenterals Ltd. vs Innova Captab Ltd.

MetricBPLPHARMA (Apr 22, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-18.2031.20
Forward P/E iN/A21.90
PEG Ratio i-0.451.33
Price to Sales (TTM) i2.392.76
Price to Book (MRQ) i1.904.05
Market Capitalization
Market Capitalization i₹8.36B₹41.43B
Enterprise Value i₹4.88B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i1.392.90
Enterprise to EBITDA i11.9020.49
Risk & Other Metrics
Beta i0.57-0.33
Book Value per Share (MRQ) i₹640.06₹178.28

Financial Statements Comparison: Bharat Parenterals Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBPLPHARMA (2025)INNOVACAP (2025)
Revenue/Sales i3.35B12.34B
Cost of Goods Sold i2.12B8.38B
COGS % of Revenue i63.1%67.9%
Gross Profit i1.24B3.96B
Gross Margin i36.9%32.1%
Research & Development i65.14MN/A
Operating Income (EBIT) i-308.90M1.65B
Operating Margin i-9.2%13.4%
EBITDA i142.48M2.00B
EBITDA Margin i4.2%16.2%
Pre-Tax Income i-339.51M1.71B
Pre-Tax Income % of Revenue i-10.1%13.9%
Income Tax i97.25M427.58M
Income Tax % of Revenue i2.9%3.5%
Net Income (Profit) i-436.75M1.28B
Profit Margin i-13.0%10.4%

Balance Sheet & Liquidity Metrics

MetricBPLPHARMA (2025)INNOVACAP (2025)
Cash & Equivalents i5.60M155.19M
Total Current Assets i3.56B7.03B
Total Current Assets % of Revenue i106.0%57.0%
Total Current Liabilities i2.19B3.53B
Total Current Liabilities % of Revenue i65.4%28.6%
Long-Term Debt i758.67M2.45B
Long-Term Debt % of Revenue i22.6%19.8%
Total Shareholders Equity i3.39B9.59B
Retained Earnings i1.75B4.53B
Retained Earnings % of Revenue i52.1%36.7%
Property, Plant & Equipment i60.23M442.93M

Cash Flow Statement Comparison

MetricBPLPHARMA (2025)INNOVACAP (2025)
Operating Cash Flow i-654.31M282.88M
Operating Cash Flow % of Revenue i-19.5%2.3%
Capital Expenditures i-286.21M-1.72B
Free Cash Flow i-563.30M-1.09B
FCF Margin i-16.8%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBPLPHARMAINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i6.89M57.22M
Float Shares i658,94715.91M
% Held by Insiders i79.74%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i20.26%8.59%

Dividend Analysis & Yield Comparison: Bharat Parenterals Ltd. vs Innova Captab Ltd.

MetricBPLPHARMAINNOVACAP
Last 12-Month Dividend i₹1.00₹2.00
Last 12-Month Dividend Yield i0.08%0.30%
3-Year Avg Annual Dividend i₹0.33₹0.67
3-Year Avg Dividend Yield i0.08%0.30%
3-Year Total Dividends i₹1.00₹2.00
Ex-Dividend DateSep 19, 2025Jan 30, 2026